A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab

Trial Profile

A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Daclizumab (Primary) ; Mycophenolate mofetil (Primary) ; Ciclosporin; Corticosteroids; Corticosteroids
  • Indications Renal transplant rejection
  • Focus Registrational; Therapeutic Use
  • Acronyms CAESAR
  • Sponsors Roche
  • Most Recent Events

    • 01 Dec 2008 Actual end date March 2004, reported by ClinicalTrials.gov.
    • 08 Aug 2006 Status change
    • 24 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top